Wall Street Zen Upgrades Henry Schein (NASDAQ:HSIC) to "Buy"

Key Points

• Henry Schein's stock rating was upgraded from "hold" to "buy" by analysts at Wall Street Zen, reflecting increased investor confidence.
• The company reported a quarterly earnings miss, posting $1.10 EPS against an expected $1.19, while reporting a revenue increase of 3.3% year-over-year.
• Despite the earnings miss, Henry Schein's average price target among analysts is $76.67, indicating potential upside from its current trading price of around $69.58.

Henry Schein (NASDAQ:HSIC - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued on Saturday.

Several other research firms have also issued reports on HSIC. Baird R W lowered Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Stifel Nicolaus restated a "hold" rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. UBS Group dropped their price objective on Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 6th. Barrington Research dropped their price objective on Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 6th. Finally, Robert W. Baird restated a "neutral" rating and issued a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $76.67.

Henry Schein Stock Down 1.9%

HSIC traded down $1.28 on Friday, hitting $67.11. 458,634 shares of the company were exchanged, compared to its average volume of 1,751,967. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a market cap of $8.14 billion, a PE ratio of 21.65, a PEG ratio of 2.30 and a beta of 0.86. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The stock's fifty day moving average is $70.22 and its 200-day moving average is $69.93.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the previous year, the company posted $1.23 EPS. The business's revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities research analysts predict that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Henry Schein

A number of large investors have recently added to or reduced their stakes in HSIC. Northern Trust Corp grew its position in Henry Schein by 17.6% during the fourth quarter. Northern Trust Corp now owns 1,376,515 shares of the company's stock worth $95,255,000 after buying an additional 206,078 shares in the last quarter. Schonfeld Strategic Advisors LLC grew its position in Henry Schein by 357.6% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 24,511 shares of the company's stock worth $1,696,000 after buying an additional 19,154 shares in the last quarter. Jane Street Group LLC grew its position in Henry Schein by 18.2% during the fourth quarter. Jane Street Group LLC now owns 25,556 shares of the company's stock worth $1,768,000 after buying an additional 3,932 shares in the last quarter. Ananym Capital Management LP acquired a new stake in Henry Schein during the fourth quarter worth approximately $32,628,000. Finally, BNP Paribas Financial Markets grew its position in Henry Schein by 20.4% during the fourth quarter. BNP Paribas Financial Markets now owns 222,057 shares of the company's stock worth $15,366,000 after buying an additional 37,575 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.